Effects of 1-year treatment with cyclophosphamide on outcomes at 2 years in scleroderma lung disease |
| |
Authors: | Tashkin Donald P,Elashoff Robert,Clements Philip J,Roth Michael D,Furst Daniel E,Silver Richard M,Goldin Jonathan,Arriola Edgar,Strange Charlie,Bolster Marcy B,Seibold James R,Riley David J,Hsu Vivien M,Varga John,Schraufnagel Dean,Theodore Arthur,Simms Robert,Wise Robert,Wigley Fred,White Barbara,Steen Virginia,Read Charles,Mayes Maureen,Parsley Ed,Mubarak Kamal,Connolly M Kari,Golden Jeffrey,Olman Mitchell,Fessler Barri,Rothfield Naomi,Metersky Mark,Khanna Dinesh,Li Ning,Li Gang Scleroderma Lung Study Research Group |
| |
Affiliation: | Department of Medicine, David Geffen School of Medicine, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, California 90095-1690, USA. dtashkin@mednet.ucla.edu |
| |
Abstract: | |
| |
Keywords: | |
本文献已被 PubMed 等数据库收录! |
|